Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer
Cc. Williams et al., Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer, MOL THER, 3(2), 2001, pp. 216-224
Weakly immunogenic, but highly malignant, rat MADB106 breast cancer cells w
ere retrovirally transduced with the membrane form of macrophage colony-sti
mulating factor (mM-CSF). The cloned mM-CSF-transfected MADB106 cells physi
cally conjugated with macrophages, but were not killed by the macrophages i
n 48-h cytotoxicity assays. Macrophages killed the mM-CSF-expressing tumors
in the presence of noncytotoxic doses of either taxol or taxol plus cispla
tin. This indicated that macrophages bind to the mM-CSF expressed on the tu
mor cells, but for successful macrophage cytotoxicity to occur against mM-C
SF-transduced tumor cells other factors must be present. The mM-CSF-transfe
cted tumor cells were rejected when inoculated subcutaneously into normal r
ats. Cloned MADB106 tumor cells which expressed high amount of mM-CSF were
rejected, while tumor cells that displayed lower levels of mM-CSF grew in 6
0% of the inoculated rats. The mM-CSF-transfected tumors that grew were sma
ller and had a greater amount of necrosis, compared to the viral vector tum
ors. Rats that spontaneously rejected the mM-CSF-transfected MADB106 cells
showed rechallenge resistance to unmodified parental MADB106 and R3230Ac br
east cancers, but not to the F98 glioma. These observations suggest that br
east cancer-specific immunity was induced by the inoculation of mM-CSF-expr
essing MADB106 tumor cells.